価格表

在庫・価格 : 2024年05月12日 13時25分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
IL-2, Human, Development Module
データシート※最新のデータシートでない場合があります
SEL202 RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥107,000
(未発注)
追加

在庫・価格 : 2024年05月12日 13時25分 現在

IL-2, Human, Development Module

  • 商品コード:SEL202
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥107,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Chong SY et al. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. Vaccine 2007 Jun;25(
Chong SY et al
2007/01/01
Species: Primate - Macaca mulatta (Rhesus monkey), Sample type: Whole Cells PubMed
2 Snyder-Cappione JE et al. A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-? and MIP1-?, a lack of IL-17, and a Th1-bias in males. PLoS ONE 2010;5(11):e15412
Snyder-Cappione JE et al
2010/01/01
Sample Type: Whole Cells PubMed
3 Joubert MK et al. Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics. PLoS ONE 2016;11(8):e0159328
Joubert MK et al
2016/01/01
Sample Type: Whole Cells PubMed
4 Sahay B et al. Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses. Viruses 2019 02;11(2)
Sahay B et al
2019/01/01
PubMed
  • No.: 1
  • 文献情報:
    Chong SY et al. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. Vaccine 2007 Jun;25(
    Chong SY et al
    2007/01/01
  • 備考:
    Species: Primate - Macaca mulatta (Rhesus monkey), Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Snyder-Cappione JE et al. A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-? and MIP1-?, a lack of IL-17, and a Th1-bias in males. PLoS ONE 2010;5(11):e15412
    Snyder-Cappione JE et al
    2010/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Joubert MK et al. Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics. PLoS ONE 2016;11(8):e0159328
    Joubert MK et al
    2016/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Sahay B et al. Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses. Viruses 2019 02;11(2)
    Sahay B et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed